Saba Labs, a startup licensing technology from Samford University, secures $2m over two separate rounds for chronic wounds medtech.

GE Ventures has extended its partnership with Startup Health Academy to attract a second group of at least 10 startups to their Entrepreneurship Program.

BioWink, the developer of fertility tracking app Clue, previously obtained seed funding from investors including Dr Kade and Groupe Arnault.

MedImmune, Amgen and GlaxoSmithKline are all set to exit Adheron in a deal that could potentially rise to $580m if all milestones are met.

The healthcare consultancy platform has received pre-series A funding from investors reportedly including media conglomerate Bennett Coleman.

Opsonix, which is developing therapies for a range of blood-borne infectious diseases, has secured $8m in a Baxter-led series A round.

The Roche-backed oncology treatment developer floated below its range in an IPO in which Pfizer and Bristol-Myers Squibb both acquired shares.

The chronic disease management platform has attracted pharmaceutical firm Merck as an investor and increased its total funding to more than $22m.

The pharmaceutical company has added $6.3m to the $17m raised from backers including Novartis, Pfizer and Partners Innovation Fund last year.